Unimed S

Unimed Medical Supplies company News and Trends items

trends.medicalexpo.com

Unimed has obtained market access qu... ... *Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates. ... © 2026 All rights reserved - Terms - Privacy policy - General Terms - Manage cookies - 鄂ICP备16017613号-1 - Unimed Class I devices are fulfilling the applicable requirements of the MDR compliance and have the qualification to continue to place these devices on the market of European Union and EEA territory after the full implementation of the MDR on May 26, 2021. Unimed has already completed ANVISA registration for ECG Lead Wires and Temperature Probes. Certified with GMP, Unimed is about to finish ANVISA registration for SpO2 sensors to obtain the access qualification for Brazilian market. From November 17–20, 2025, Unimed Medical will exhibit at Hall 11, Booth D32 at MEDICA in Düsseldorf, Germany, presenting its full range of patient monitoring accessories and parts, built on over 20 years of medical expertise and innovation.

Unimed - 2026 Company Profile, Competitors & Financials - Tracxn

tracxn.com

Unimed - Provider of medical supplies such as SpO2 sensors, ECG cables, and patient monitoring accessories. Unimed has 4 employees as of Oct 24. Here is Unimed's employee count trend over the years: Unimed is an unfunded company based in Leicester (United Kingdom), founded in 2018. It operates as a Provider of medical supplies such as SpO2 sensors, ECG cables, and patient monitoring accessories. Unimed has not raised any funding yet. The company has 92 active competitors, including 2 funded and 20 that have exited. Unimed is a global provider of advanced medical supplies including patient monitoring accessories. They also offer high-end massagers and health insurance plans tailored for workplace settings.

Unimed Company Overview, Contact Details & Competitors | LeadIQ

leadiq.com

Unimed uses 8 technology products and services including Google AdSense, Adobe, Joomla, and more. Explore Unimed's tech stack below. ... Unimed is a publicly traded company; the company's stock symbol is UMED1. Unimed's official website is unimed.coop.br and has social profiles on LinkedIn. As of July 2026, Unimed's annual revenue is estimated to be $100M - $250M. As of July 2026, Unimed has approximately 85K employees across 6 continents, including South AmericaAsiaAfrica. Key team members include Chief Executive Officer: S. A.Cto: W. M.Cio: L. G.. Explore Unimed's employee directory with LeadIQ. Market leadership Unimed is the largest medical cooperative system in the world with a broad network of 341 cooperatives and 118k+ doctors, indicating a wide potential customer base and referrals across regions for healthcare IT, compliance, and provider-facing solutions. Unimed is a Brazilian organization in the Government Administration sector, headquartered at 1827 Alameda Santos, São Paulo, São Paulo, Brazil. It positions itself as the world's largest cooperative system of physicians. Founded in 1967 with the establishment of Unimed Santos (SP), the system has grown to include 341 medical cooperatives, more than 118,000 doctors, and serves about 19 million beneficiaries.

UMED Technical Analysis, RSI and Moving Averages - Investing.com

www.investing.com

Track the 200-day and 50-day moving averages to assess long-term and short-term trends, while identifying key buy or sell signals. This page provides a comprehensive breakdown of technical indicators to help you evaluate Unite de Fabrication de Medicaments SA (UMED)'s performance. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Central Nacional Unimed 2026 Company Profile: Valuation, Funding ...

pitchbook.com

Operator of national Unimed health plans intended to offer corporate medical assistance and special benefit services. The company offers corporate health care, special benefits, and differentiated care, as well as provides hospital, medical, and other health services, enabling clients to get full health assistance. ... Explore institutional-grade private market research from our team of analysts. Central Nacional Unimed is headquartered in Sao Paulo, Brazil. Central Nacional Unimed has 1,653 total employees. Central Nacional Unimed’s primary industry is Life and Health Insurance.

Unimed outlines its pharmaceutical growth path as investors watch ...

www.ad-hoc-news.de

This mix of regulatory compliance and operational efficiency is critical for sustaining margins in a competitive market. Demand for pharmaceuticals in North Africa is shaped by demographic trends, rising healthcare coverage, and the growing burden of chronic diseases. Unimed’s position as a regional producer allows it to serve local needs with products tailored to national reimbursement systems and prescribing habits. The balance between maintaining affordability and preserving profitability is particularly important in markets where public-sector purchasing plays a major role. Over the long term, scale effects and a diversified product range can help stabilize earnings in the face of these challenges. Unimed’s portfolio typically spans several therapeutic segments such as cardiovascular, anti-infective, and gastrointestinal treatments, as well as other commonly prescribed categories. Unimed is associated with the ISIN TN0007230011 and is linked to the Tunisian equity market. The company represents exposure to the regional pharmaceutical sector, where share performance is influenced by earnings trends, regulatory developments, and broader investor sentiment toward emerging-market healthcare companies. The company’s strategy and market footprint are central for investors tracking North African healthcare exposure. ... Unimed is a Tunisian pharmaceutical company focused on prescription medicines and healthcare products, and its shares are associated with the ISIN TN0007230011.